Journal article

Spatially restricted hyaluronan production by Has2 drives epithelial tubulogenesis in vitro.

  • Soulié P Department of Cell Physiology and Metabolism, University of Geneva Medical School, Geneva, Switzerland.
  • Chassot A Department of Cell Physiology and Metabolism, University of Geneva Medical School, Geneva, Switzerland.
  • Ernandez T Department of Cell Physiology and Metabolism, University of Geneva Medical School, Geneva, Switzerland.
  • Montesano R Department of Cell Physiology and Metabolism, University of Geneva Medical School, Geneva, Switzerland.
  • Féraille E Department of Cell Physiology and Metabolism, University of Geneva Medical School, Geneva, Switzerland eric.feraille@unige.ch.
  • 2014-08-29
Published in:
  • American journal of physiology. Cell physiology. - 2014
English Generation of branched tubes from an epithelial bud is a fundamental process in development. We hypothesized that induction of hyaluronan synthase (Has) and production of hyaluronan (HA) drives tubulogenesis in response to morphogenetic cytokines. Treatment of J3B1A mammary cells with transforming growth factor-β1 or renal MDCK and mCCD-N21 cells with hepatocyte growth factor induced strong and specific expression of Has2. Immunostaining revealed that HA was preferentially produced at the tips of growing tubules. Inhibition of HA production, either by 4-methylumbelliferone (4-MU) or by Has2 mRNA silencing, abrogated tubule formation. HA production by J3B1A and mCCD-N21 cells was associated with sustained activation of ERK and S6 phosphorylation. However, silencing of either CD44 or RHAMM (receptor for HA-mediated motility), the major HA receptors, by RNA interference, did not alter tubulogenesis, suggesting that this process is not receptor-mediated.
Language
  • English
Open access status
green
Identifiers
Persistent URL
https://sonar.ch/global/documents/106377
Statistics

Document views: 45 File downloads:
  • Full-text: 0